Intrinsiqs

Is Opus Genetics, Inc. overvalued?

Opus Genetics, Inc. (IRD) — key valuation metrics and fundamentals.

No verdict
Price
$5.05
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$417.0M
Dividend yield
0.0%
Return on equity
1147.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares IRD's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.